A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy
Clinical trial NCT00000842 · COMPLETED
Trial details
- NCT number
- NCT00000842
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.